These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
37 related articles for article (PubMed ID: 16311736)
21. Clinical impact of bortezomib in frontline regimens for patients with multiple myeloma. Manochakian R; Miller KC; Chanan-Khan AA Oncologist; 2007 Aug; 12(8):978-90. PubMed ID: 17766658 [TBL] [Abstract][Full Text] [Related]
22. A practical update on the use of bortezomib in the management of multiple myeloma. San Miguel J; Bladé J; Boccadoro M; Cavenagh J; Glasmacher A; Jagannath S; Lonial S; Orlowski RZ; Sonneveld P; Ludwig H Oncologist; 2006 Jan; 11(1):51-61. PubMed ID: 16401713 [TBL] [Abstract][Full Text] [Related]
23. Use of bortezomib in B-cell non-Hodgkin's lymphoma. Wang M; Zhou Y; Zhang L; Nguyen CA; Romaguera J Expert Rev Anticancer Ther; 2006 Jul; 6(7):983-91. PubMed ID: 16831071 [TBL] [Abstract][Full Text] [Related]
24. Targeted treatments to improve stem cell outcome: old and new drugs. Raab MS; Breitkreutz I; Anderson KC Bone Marrow Transplant; 2007 Dec; 40(12):1129-37. PubMed ID: 17768392 [TBL] [Abstract][Full Text] [Related]
25. Management of multiple myeloma with bortezomib: experts review the data and debate the issues. Dicato M; Boccadoro M; Cavenagh J; Harousseau JL; Ludwig H; San Miguel J; Sonneveld P Oncology; 2006; 70(6):474-82. PubMed ID: 17283449 [TBL] [Abstract][Full Text] [Related]
27. Bortezomib: killing two birds with one stone in gastrointestinal stromal tumors. Duensing S; Duensing A Oncotarget; 2010 May; 1(1):6-8. PubMed ID: 21293050 [No Abstract] [Full Text] [Related]
29. Complete remission and successful stem cell mobilization after treatment of refractory plasma cell leukemia with bortezomib. Grassinger J; Südhoff T; Andreesen R; Hennemann B Ann Hematol; 2006 Feb; 85(2):132-3. PubMed ID: 16311736 [No Abstract] [Full Text] [Related]
30. Bortezomib in multiple myeloma. Mateos MV; San Miguel JF Best Pract Res Clin Haematol; 2007 Dec; 20(4):701-15. PubMed ID: 18070714 [TBL] [Abstract][Full Text] [Related]
32. Bortezomib in the front-line treatment of multiple myeloma. Richardson PG; Mitsiades C; Schlossman R; Ghobrial I; Hideshima T; Munshi N; Anderson KC Expert Rev Anticancer Ther; 2008 Jul; 8(7):1053-72. PubMed ID: 18588451 [TBL] [Abstract][Full Text] [Related]
33. Incorporating bortezomib into the treatment of lung cancer. Davies AM; Lara PN; Mack PC; Gandara DR Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4647-51. PubMed ID: 17671158 [TBL] [Abstract][Full Text] [Related]
34. The role of bortezomib in the treatment of lymphoma. Barr P; Fisher R; Friedberg J Cancer Invest; 2007 Dec; 25(8):766-75. PubMed ID: 18058474 [TBL] [Abstract][Full Text] [Related]